Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Journal of Neuroinflammation|December 25, 2019
Molecular biomarkers in multiple sclerosisTjalf Ziemssen, Katja Akgün, Wolfgang BrückExpert Opinion on Drug Metabolism & Toxicology|October 19, 2022
Current status and new developments in sphingosine-1-phosphate receptor antagonism: fingolimod and moreVictor Constantinescu, Katja Akgün, Tjalf ZiemssenJournal of Central Nervous System Disease|March 20, 2019
Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational StudiesKatja Akgün, Ute Essner, Cordula Seydel, et al.Therapeutic Advances in Neurological Disorders|November 28, 2022
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative reviewVictor Constantinescu, Rocco Haase, Katja Akgün, et al.Frontiers in Neurology|May 3, 2021
Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple SclerosisUndine Proschmann, Hernan Inojosa, Katja Akgün, et al.Fortschritte Der Neurologie-Psychiatrie|March 16, 2021
[MSProDiscuss - Development of a Digital Anamnesis Tool to Identify Disease Progression in Multiple Sclerosis]Hernan Inojosa, Katja Akgün, Katrin Haacke, et al.Cells|November 27, 2021
Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side EffectsStefanie Fischer, Undine Proschmann, Katja Akgün, et al.Frontiers in Neurology|June 2, 2020
Fingolimod Leads to Immediate Immunological Changes Within 6 h After First AdministrationTony Sehr, Katja Akgün, Rocco Haase, et al.Frontiers in Immunology|August 12, 2022
Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responsesChristina Woopen, Urszula Konofalska, Katja Akgün, et al.Frontiers in Pharmacology|October 4, 2024
Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosisVictor Constantinescu, Rocco Haase, Katja Akgün, et al.Pageof 10